Invesco Nasdaq Biotechnology ETF Rating $21.72 +0.13 (+0.58%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.70Holdings in IBBQ have an aggregate rating of Moderate Buy based on 769 analyst ratings issued in the past year covering 50 companies (80.3% of the portfolio).IBBQ Aggregate Price Target$21.72High Prediction$21.72Average Prediction$21.72Low Prediction$21.72Holdings in IBBQ have an aggregate price target of $21.72 and a range of $21.72 to $21.72 covering 50 companies (80.3% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.83%VRTXVertex Pharmaceuticals$454.64-0.5%4.7263 of 5 stars2.54$511.62 12.5%28Positive News7.77%GILDGilead Sciences$111.28-0.2%4.8432 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade7.72%AMGNAmgen$298.25+0.5%4.5296 of 5 stars2.35$307.82 3.2%23Positive News6.23%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9558 of 5 stars2.80$813.57 49.3%254.67%AZNAstraZeneca$69.60-2.2%3.0763 of 5 stars2.83$85.00 22.1%6Positive News4.04%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.2984 of 5 stars2.79$340.00 2.4%24Analyst Upgrade2.10%BIIBBiogen$132.63-0.4%4.9313 of 5 stars2.38$188.48 42.1%321.96%INSMInsmed$98.50+0.3%4.1548 of 5 stars3.00$106.80 8.4%17Positive News1.89%ARGXargenex$543.32-0.3%4.3905 of 5 stars3.05$728.06 34.0%21Analyst Forecast1.74%SMMTSummit Therapeutics$24.35+7.6%2.5141 of 5 stars2.79$34.67 42.4%14Trending NewsAnalyst ForecastOptions VolumeHigh Trading Volume1.72%ILMNIllumina$100.44+0.1%4.8755 of 5 stars2.47$127.39 26.8%19Positive News1.67%RPRXRoyalty Pharma$36.33+0.4%4.9175 of 5 stars3.25$47.33 30.3%4Positive News1.52%SNYSanofi$48.89-0.9%4.1696 of 5 stars3.11$61.50 25.8%9Analyst Forecast1.47%INCYIncyte$68.46+0.4%4.4344 of 5 stars2.22$74.53 8.9%181.45%UTHRUnited Therapeutics$294.57-0.2%4.9947 of 5 stars2.69$386.15 31.1%13Positive News1.40%NBIXNeurocrine Biosciences$128.04-1.1%4.9236 of 5 stars2.86$162.00 26.5%22Positive News1.32%EXELExelixis$45.91+3.6%4.7433 of 5 stars2.52$43.56 -5.1%21Trending NewsAnalyst RevisionHigh Trading Volume1.23%MRNAModerna$30.47+0.6%4.3797 of 5 stars2.04$46.61 53.0%23Options Volume1.19%VTRSViatris$9.25-1.0%2.6727 of 5 stars1.80$10.40 12.4%51.19%BNTXBioNTech$109.65+1.3%2.3285 of 5 stars2.83$137.86 25.7%181.19%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9465 of 5 stars2.75$93.61 63.5%24Analyst Forecast1.15%ASNDAscendis Pharma A/S$174.07+0.6%3.5057 of 5 stars3.00$220.67 26.8%15News CoverageAnalyst Forecast1.12%ONCBeOne Medicines$245.49+0.5%3.0139 of 5 stars3.00$320.67 30.6%61.11%TEMTempus AI$60.65+2.5%2.2834 of 5 stars2.54$63.67 5.0%13Trending News1.02%MEDPMedpace$321.50-1.4%4.4598 of 5 stars2.21$344.82 7.3%140.92%BPMCBlueprint Medicines$128.27+0.1%1.5646 of 5 stars2.27$128.06 -0.2%220.90%BBIOBridgeBio Pharma$43.71+2.0%4.6902 of 5 stars2.93$58.85 34.6%14News CoverageInsider TradeAnalyst Revision0.82%ROIVRoivant Sciences$10.85-1.1%1.5415 of 5 stars3.00$17.50 61.4%40.79%VRNAVerona Pharma PLC American Depositary Share$91.18+1.2%2.6057 of 5 stars3.00$107.36 17.7%12Positive NewsAnalyst Forecast0.76%RVMDRevolution Medicines$37.00-0.5%4.5785 of 5 stars3.00$67.58 82.7%12Analyst Revision0.75%JAZZJazz Pharmaceuticals$109.45-0.4%4.8999 of 5 stars2.92$184.00 68.1%13Insider Trade0.74%MDGLMadrigal Pharmaceuticals$298.49-0.6%4.0879 of 5 stars2.89$420.63 40.9%90.72%HALOHalozyme Therapeutics$54.05+0.4%4.8234 of 5 stars2.17$61.90 14.5%120.70%IONSIonis Pharmaceuticals$42.98-1.4%4.6752 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade0.69%GHGuardant Health$50.25+0.1%3.7582 of 5 stars3.00$53.76 7.0%21Insider Trade0.57%NUVLNuvalent$80.37-0.2%3.734 of 5 stars3.17$119.60 48.8%12Insider Trade0.56%AXSMAxsome Therapeutics$105.36+1.4%4.7429 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision0.53%ALKSAlkermes$28.75-0.9%4.9367 of 5 stars2.83$40.00 39.1%12Positive NewsAnalyst Revision0.47%ADMAADMA Biologics$18.30+0.9%4.2263 of 5 stars3.33$27.67 51.2%3Positive News0.47%PCVXVaxcyte$33.24-0.1%1.7969 of 5 stars3.10$136.50 310.7%10News Coverage0.46%RYTMRhythm Pharmaceuticals$65.78-1.7%3.8074 of 5 stars3.00$77.31 17.5%13News Coverage0.46%CRSPCRISPR Therapeutics$52.16+0.9%3.0197 of 5 stars2.53$71.75 37.6%170.45%AKROAkero Therapeutics$52.01+0.3%3.4697 of 5 stars3.00$82.50 58.6%6Insider Trade0.44%CYTKCytokinetics$33.90-1.3%3.9341 of 5 stars2.93$70.92 109.2%150.44%KRYSKrystal Biotech$143.01+1.2%4.5851 of 5 stars3.00$211.13 47.6%9News CoverageAnalyst Revision0.43%PTCTPTC Therapeutics$48.77-0.8%4.3213 of 5 stars2.67$65.00 33.3%15Analyst Revision0.40%MRUSMerus$53.84+1.0%1.8603 of 5 stars3.14$84.64 57.2%140.40%ACADACADIA Pharmaceuticals$20.95-1.4%4.624 of 5 stars2.71$27.88 33.1%170.39%ACLXArcellx$67.30+1.4%2.9577 of 5 stars3.07$111.23 65.3%150.38%RNAAvidity Biosciences$29.13-0.8%1.8242 of 5 stars3.06$65.59 125.2%17 This page (NASDAQ:IBBQ) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBBQ Stock Alerts